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Background
Hereditary amyloidosis represents approximately 4% of the
total cases of amyloidoses. The most frequent familial type
is caused by deposition of mutated transthyretin (TTR,
prealbumin). So far it has been identified more than 100
mutations in the transthyretin gene and type of causal
mutation is also characterized by a clinical picture of the
disease. The most common variant is a neuropathic dis-
ease. Characteristic feature is an endemic occurrence with
very low incidence in the Central Europe countries.
Methods
The aim of this communication is to present case of a
patient with an inherited form of the TTR amyloidosis
which is extremely rare in the Czech Republic.
Results
25-year-old patient was examined for a history of two
years lasting and gradually progressing paresthesias of
the lower limbs associated with instability, reduced mus-
cle strength, dysesthesias and peroneal gait. In the last
year, also present with intermittent dyspepsia, loss of
weight was 10 kg (BMI 16.3, BMI 717.2). On the basis of
clinical and EMG finding he was treated as CIDP with
i.v. pulses of methylprednisolone, followed by mainte-
nance therapy with prednisone and azathioprin. After-
wards the dyspepsia developed. Gastric endoscopy with
biopsy revealed massive deposits of amyloid. Family his-
tory clarify amyloidosis with neurological impairment in
the patient’s mother. Immunohistochemistry confirmed
strong positivity of transthyretin in amyloid masses. The
sequencing of TTR gene confirmed mutation c.149T˃C
with the effect on the coding sequence Val50Ala in
heterozygous status. The patient was then registered on
the waiting list for OLT. Due to rapid progression of neu-
ropathic involvement despite conservative therapy, ther-
apy with Vyndaqel cps. (Tafamidis meglutime, Pfizer)
was initiated at a dose of 20mg per day. Therapy led to a
halt of further progression of neuropathic disability,
improvement of nutrition and overall improvement of
the condition of the patient. 19 months after diagnosis,
OLT was performed with good postoperative course.
As complications, the early cortico-sensitive rejection
episode and bronchopneumonia developed. Currently,
the patient is intensively rehabilitating with gradual
regression of neuropathic symptoms and improvement of
nutritional status (BMI 17.9, mBMI 841).
Conclusions
Although the Czech Republic is not endemic country for
the incidence of familial TTR amyloidosis, it is important
to consider this clinical entity, especially in the case of
family history. Correct differential diagnosis belongs to
the fundamental aspects of care for these patients.
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